[1]王辞晓,赵良斌,黄佑群.益气活血补肾方联合厄贝沙坦对高血压性肾损害患者肾功能的保护作用[J].陕西中医,2021,(6):735-738.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
　WANG Cixiao,ZHAO Liangbin,HUANG Youqun.Protective effect of Yiqi Huoxue Bushen recipe combined with irbesartan on renal function in patients with hypertensive renal damage[J].,2021,(6):735-738.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.014]
点击复制

益气活血补肾方联合厄贝沙坦对高血压性肾损害患者肾功能的保护作用
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年6期
页码:
735-738
栏目:
临床研究
出版日期:
2021-06-05

文章信息/Info

Title:
Protective effect of Yiqi Huoxue Bushen recipe combined with irbesartan on renal function in patients with hypertensive renal damage
作者:
王辞晓; 赵良斌; 黄佑群
(成都中医药大学附属医院肾病二科,四川 成都 610072)
Author(s):
WANG Cixiao; ZHAO Liangbin; HUANG Youqun
(Department of Nephrology Second,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
关键词:
高血压;  肾损害;  益气活血补肾方;  厄贝沙坦;  炎症因子
Keywords:
Hypertension;  Kidney damage;  Yiqi Huoxue Bushen recipe;  Irbesartan;  Inflammatory factors
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.06.014
文献标志码:
A
摘要:
目的:观察益气活血补肾方联合厄贝沙坦治疗高血压性肾损害疗效及对患者炎症因子的影响。方法:选取100例高血压性肾损害患者,随机分为试验组、对照组,每组50例。对照组给予厄贝沙坦治疗,试验组给予益气活血补肾方联合厄贝沙坦治疗,两组均治疗12周。比较两组治疗前后血压、肾功能指标及炎症因子水平。结果:治疗前,两组患者收缩压、舒张压比较,差异无统计学意义(均P>0.05)。治疗后两组患者收缩压、舒张压较治疗前降低,且试验组低于对照组,差异有统计学意义(均P<0.05)。治疗后两组β2-微球蛋白、胱抑素C、尿微量白蛋白、白介素-6、肿瘤坏死因子-α表达水平均低于治疗前,且试验组低于对照组,差异有统计学意义(均P<0.05)。治疗后两组IL-10水平高于治疗前,且试验组高于对照组,差异有统计学意义(均P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:益气活血补肾方联合厄贝沙坦治疗高血压性肾损害,在降低患者血压、改善肾功能、抑制炎症反应方面具有积极意义。
Abstract:
Objective:To observe clinical efficacy of Yiqi Huoxue Bushen decoction combined with irbesartan in the treatment of patients with hypertensive renal damage and its influence on inflammatory factors.Methods:100 patients with hypertensive renal impairment were selected and divided into test group and control group,50 cases in each group.The control group was treated with irbesartan,and the test group treated with Yiqi Huoxue Bushen decoction combined with irbesartan.The total course of treatment was 12 weeks.Blood pressure,renal function indexes and inflammatory factor levels between the two groups before and after treatment were compared.Results:There was no significant difference in systolic blood pressure and diastolic blood pressures before treatment between the two groups(all P>0.05).After treatment,systolic and diastolic blood pressure were lower in both groups than before,and the test group was lower than the control group,difference statistically significant(all P<0.05).After treatment,the expression levels of β2-MG,Cys-C,urinary microalbumin,IL-6,TNF-α in both groups were lower than before treatment,and the test group was lower than the control group,difference statistically significant(all P<0.05).After treatment,the IL-10 level of the two groups were higher than before treatment,and the test group was higher than that of the control group,difference statistically significant(all P<0.05).Comparison of adverse reaction rates between the two groups was not statistically significant(P>0.05).Conclusion:Yiqi Huoxue Bushen recipe combined with irbesartan in the treatment of hypertensive renal damage,it has positive significance in reducing blood pressure,improving renal function and inhibiting inflammatory response.

参考文献/References:

[1] 王梦楠,刘军红,张瑞芳,等.厄贝沙坦联合六味地黄丸对阴虚阳亢型原发性高血压伴早期肾损害病人炎性因子的影响[J].中西医结合心脑血管病杂志,2020,18(4):635-638.
[2] Buffet L,Ricchetti C.Chronic kidney disease and hypertension:A destructive combination[J].USA Pharmacist,2012,37(6):26-29.
[3] 年士艳,冯 磊,赵 阳.益气活血补肾颗粒对原发性高血压早期肾损伤患者外周血Cys-C、IMD、FGF23、APN、ET-1、CGRP的影响[J].中药材,2019,42(6):1421-1424.
[4] 中国高血压防治指南修订委员会.中国高血压防治指南[J].中华高血压杂志,2011,19(8):701-743.
[5] Pandey NR.Significance of blood pressure variability in patients with sepsis[J].World Journal of Emergency Medicine,2014,5(1):42-50.
[6] Buffet L,Ricchetti C.Chronic kidney disease and hypertension:A destructive combination[J].USA Pharmacist,2012,37(6):26-29.
[7] Luo D,Xu J,Chen X,et al.Epigallocatechin-3-gallate attenuates salt-induced hypertension and renal injury in dahl salt-sensitive rats[J].Scientific Reports,2020,10(1):4783-4788.
[8] Qu ZS,Zhang QD,Li L.Impact of low-dose urokinase in peritoneal dialysis on serum oxidative stress nitric oxide and endothelin in cerebral infarction complicated with uremia[J].International Journal of Clinical & Experimental Medicine,2015,8(1):1333-1341.
[9] 高 霞,苗迎春,李子富,等.阿司匹林联合厄贝沙坦治疗原发性高血压合并冠心病疗效及对患者凝血功能影响[J].陕西医学杂志,2018,47(10):1337-1339.
[10] 吴冠吉,李春花,张 涛,等.厄贝沙坦对糖尿病合并高血压患者血清脂联素水平影响研究[J].陕西医学杂志,2018,47(8):1056-1058.
[11] 欧阳雅蓉,傅为武,黄彩依,等.自噬在高血压靶器官损害中的作用及中医药治疗研究进展[J].陕西中医,2020,41(11):1669-1672.
[12] 白起君,黄 捷,周晓亚,等.清眩补肾汤治疗原发性高血压疗效及对患者肾素-血管紧张素-醛固酮影响[J].陕西中医,2019,40(3):311-314.
[13] Alessandro A,Kasmi KC,Plecita HL,et al.Hallmarks of pulmonary hypertension:Mesenchymal and inflammatory cell metabolic reprogramming[J].Antioxidants & Redox Signaling,2018,28(3):230-250.
[14] 许旭光,孔刘莎,韩 菡.贝前列素钠联合缬沙坦治疗高血压肾损害的疗效观察[J].基层医学论坛,2017,21(20):2603-2606.
[15] Korim WS,Elsaafien K,Basser JR,et al.In renovascular hypertension TNF-α type-1 receptors in the area postrema mediate increases in cardiac and renal sympathetic nerve activity and blood pressure[J].Cardiovascular Research,2019,115(6):1092-1101.
[16] Furusho T,Sohara E,Mandai S,et al.Renal TNF-α activates the wnk phosphorylation cascade and contributes to salt-sensitive hypertension in chronic kidney disease[J].Kidney International,2020,97(4):713.
[17] 陈俊民,程 文,郭瑞瑞.高血压肾损害患者肾动脉阻力指数、TNF-α和IL-10的变化及其相关性[J].中国实验诊断学,2015,19(7):1177-1179.
[18] Maria WK,Elbieta P,Andrzej T.Association between serum level of TGF-β1 leptin IL-6 and hypertension in chronic renal failure patients undergoing hemodialysis therapy[J].Nadcisnienie Tetnicze,2013,17(1):16-22.
[19] Pouvreau C,Antoine D,Eugene B,et al.Inflammation and oxidative stress markers in diabetes and hypertension[J].Journal of Inflammation Research,2018,11(10):61-68.
[20] Polina I,Domondon M,Fox R,et al.The differential effects of low dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension[J].American Journal of Physiology Renal Physiology,2020,319(1):1823-1827.
[21] 左秀玲,朴金龙,薛丰田,等.黄连素对2型糖尿病大鼠血脂调节作用及对IL-6、IL-10及CRP水平的影响[J].陕西中医,2018,39(8):1001-1003.

相似文献/References:

[1]杨 敏,姜钧文,肖 蕾.中医体质与急性心肌梗死及其危险因素的相关性研究*[J].陕西中医,2019,(4):437.
　YANG Min,JIANG Junwen,XIAO Lei..Study on the correlation between constitution of traditional Chinese medicine and acute myocardial infarction and its risk factors[J].,2019,(6):437.
[2]高京宏,于 龙 △,王翠娟.大秦艽汤治疗颈椎病性高血压临床研究[J].陕西中医,2019,(5):597.
　GAO Jinghong,YU Long,WANG Cuijuan..Clinical observation of Daqinjiao decoction in the treatment of cervical spondylotic hypertension[J].,2019,(6):597.
[3]侯红霞,张春红.熄风通络汤联合西药治疗对高血压患者血管内皮功能的影响*[J].陕西中医,2019,(7):875.
　HOU Hongxia,ZHANG Chunhong..Effects of Xifeng Tongluo decoction combined with western medicine on vascular endothelial function in patients with hypertension[J].,2019,(6):875.
[4]钱卫东,侍煜景△.宁脉安神颗粒治疗女性更年期高血压疗效及对患者中医证候、血压变异性的影响*[J].陕西中医,2019,(9):1202.
　QIAN Weidong,SHI Yujing..Effects of Ningmai Anshen granule on TCM syndrome and blood pressure variability in women with climacteric hypertension[J].,2019,(6):1202.
[5]郭春霞,陈震霖△.中医从心肝肾论治高血压病现代作用机制及优势探讨*[J].陕西中医,2020,(5):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
　GUO Chunxia,CHEN Zhenlin..Study on Modern mechanism and advantage of TCM treating hypertension on aspects of the heart,liver and kidney[J].,2020,(6):650.[doi:DOI:10.3969/j.issn.10007369.2020.05.027]
[6]钟 路,尹胡海,黄 婕,等.从热毒学说论治高血压*[J].陕西中医,2020,(8):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
　ZHONG Lu,YIN Huhai,HUANG Jie,et al.Treatment of hypertension by heat toxicology[J].,2020,(6):1131.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.032]
[7]朱舜明,张学军,张荣怀,等.生脉注射液联合靶剂量比索洛尔对高血压伴心力衰竭患者血管内皮功能和心功能的影响*[J].陕西中医,2020,(10):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
　ZHU Shunming,ZHANG Xuejun,ZHANG Ronghuai,et al.Effects of Shengmai injection combined with target dose bisoprolol on vascular endothelial function and cardiac function in patients with hypertension and heart failure[J].,2020,(6):1403.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.017]
[8]欧阳雅蓉,傅为武,黄彩依,等.自噬在高血压靶器官损害中的作用及中医药治疗研究进展*[J].陕西中医,2020,(11):1669.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.040]
[9]邱思婕,李新梅.平肝化痰法联合西药治疗老年高血压疗效及对患者血压变异性、臂踝脉搏波传导速度、踝臂指数的影响[J].陕西中医,2021,(8):1056.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]
　QIU Sijie,LI Xinmei.Clinical curative effect of Pinggan Huatan method combined with western medicine on elderly hypertension and its influences on blood pressure variability,brachial-ankle pulse wave velocity and ankle-brachial index[J].,2021,(6):1056.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.017]
[10]舒 娅,杨华元.中医时间医学在针刺治疗高血压中的降压作用研究进展[J].陕西中医,2021,(10):1483.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.042]

备注/Memo

备注/Memo:
基金项目:国家中医药管理局科研课题(CJJ2019064)
更新日期/Last Update: 2021-06-09